Chemed (CHE) Stock Price, News & Analysis

Company Overview

Chemed Corporation is a diversified service company headquartered in Cincinnati, Ohio, with roots dating back to 1969. The company operates through two primary business segments—VITAS Healthcare and Roto-Rooter—each of which holds a leading market position in its respective field. Over the decades, Chemed has expanded both organically and through strategic acquisitions, forging a reputation as a reliable provider of essential services in North America.

Roto-Rooter, acquired by Chemed in 1980, is one of the largest providers of plumbing and drain cleaning services in the United States and Canada. The division offers a comprehensive suite of residential and commercial plumbing solutions, including emergency repairs, routine maintenance, sewer line services and water restoration. With a network of locally branded service centers staffed by trained technicians, Roto-Rooter has built strong brand recognition and a reputation for rapid response times and high-quality workmanship.

VITAS Healthcare, which became part of Chemed in 1998, is a pioneer in end-of-life care and one of the nation’s largest hospice providers. Operating across multiple states, VITAS delivers interdisciplinary care that encompasses medical, emotional and spiritual support to patients and families confronting life-limiting illness. Through a blend of in-home visits, outpatient services and residential care centers, VITAS has served hundreds of thousands of individuals, emphasizing comfort, dignity and quality of life in its approach.

Under the leadership of President and Chief Executive Officer Ronald P. Spelzer, Chemed continues to focus on service excellence and selective expansion. The company invests in technology, staff training and community outreach to enhance operational efficiency and patient or customer satisfaction. As it seeks to broaden its geographic footprint and service offerings, Chemed remains committed to its longstanding mission of delivering responsive, high-quality care and repair services across North America.

Key Stats

• Today's Range: $475.25 to $487.98
• 50-Day Range: $483.58 to $587.26
• 52-Week Range: $473.55 to $623.61
• Volume: 315,617 shs
• Average Volume: 110,167 shs
• Market Capitalization: $7.07 billion
• P/E Ratio: 23.55
• Dividend Yield: 0.41%
• Price Target: $645.00
• Consensus Rating: Buy

Chemed Stock Analysis - MarketRank™

Chemed scored higher than 99% of companies evaluated by MarketBeat, and ranked 11th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Chemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Chemed has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.73%

Earnings Growth

Earnings for Chemed are expected to grow by 8.73% in the coming year, from $21.43 to $23.30 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Chemed is 23.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of Chemed is 23.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.22.

Price to Earnings Growth Ratio

Chemed has a PEG Ratio of 2.02. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Chemed has a P/B Ratio of 6.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.53% of the float of Chemed has been sold short.

Short Interest Ratio / Days to Cover

Chemed has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Chemed has recently increased by 19.77%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Chemed has a dividend yield of 0.41%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Chemed has been increasing its dividend for 16 years.

Dividend Coverage

The dividend payout ratio of Chemed is 9.74%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Chemed will have a dividend payout ratio of 8.58% next year. This indicates that Chemed will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.9 / 5
• Environmental Score: -0.33

Percentage of Shares Shorted

3.53% of the float of Chemed has been sold short.

Short Interest Ratio / Days to Cover

Chemed has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Chemed has recently increased by 19.77%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.22

News Sentiment

Chemed has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 20 news articles for Chemed this week, compared to 9 articles on an average week.

Search Interest

6 people have searched for CHE on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,598,450.00 in company stock.

Percentage Held by Insiders

Only 3.29% of the stock of Chemed is held by insiders.

Percentage Held by Institutions

95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CHE Stock Analysis - Frequently Asked Questions

How have CHE shares performed this year?

Chemed's stock was trading at $529.80 at the start of the year. Since then, CHE stock has decreased by 8.7% and is now trading at $483.5780.
View the best growth stocks for 2025 here.

How were Chemed's earnings last quarter?

Chemed Corporation (NYSE:CHE) announced its quarterly earnings results on Wednesday, April, 23rd. The company reported $5.63 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.04. The firm's quarterly revenue was up 9.8% compared to the same quarter last year.
Read the conference call transcript.

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 4/23/2025
• Record date for 6/17 Dividend: 5/29/2025
• Ex-Dividend for 6/17 Dividend: 5/29/2025
• Dividend Payable: 6/17/2025
• Today: 7/02/2025
• Next Earnings (Estimated): 7/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Health Care Services
• Current Symbol: NYSE:CHE
• CIK: 19584
• Web: www.chemed.com
• Phone: (513) 762-6690
• Fax: 513-762-6590
• Employees: 14,200
• Year Founded: 1970

Price Target and Rating

• Average Stock Price Target: $645.00
• High Stock Price Target: $650.00
• Low Stock Price Target: $640.00
• Potential Upside/Downside: +33.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $20.53
• Trailing P/E Ratio: 23.55
• Forward P/E Ratio: 22.57
• P/E Growth: 2.02
• Net Income: $302 million
• Net Margins: 12.40%
• Pretax Margin: 16.50%
• Return on Equity: 27.58%
• Return on Assets: 18.96%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.73
• Quick Ratio: 1.70

Sales & Book Value

• Annual Sales: $2.43 billion
• Price / Sales: 2.91
• Cash Flow: $25.53 per share
• Price / Cash Flow: 18.94
• Book Value: $74.35 per share
• Price / Book: 6.50

Miscellaneous

• Outstanding Shares: 14,630,000
• Free Float: 14,148,000
• Market Cap: $7.07 billion
• Optionable: Optionable
• Beta: 0.50